Detroit Regional Chamber > Business Resources > COVID-19 > Macomb County Health Department Announces Availability of Pfizer Covid-19 Booster Vaccinations for Eligible Individuals

Macomb County Health Department Announces Availability of Pfizer Covid-19 Booster Vaccinations for Eligible Individuals

October 7, 2021
Following the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) approval of a booster dose of the Pfizer COVID-19 vaccine for select groups of people, the Macomb County Health Department is currently taking appointments for individuals who are eligible.

Those eligible for the booster doses include individuals 65 years of age and older; individuals who live in long-term care facilities; individuals 18-64 years of age with underlying medical conditions and who are at an increased risk for COVID-19 exposure and transmission because of their occupational or institutional setting. Individuals should receive their booster dose at least 6 months after they completed their primary 2-dose vaccine series.

“We’re committed to making sure that anyone who is eligible, and wants to receive a booster dose, is able to do so,” said Andrew Cox, Director/Health Officer of the Macomb County Health Department, “Our staff of health care professionals are more than ready to continue to deliver exceptional service to the residents of Macomb County.”

Booster dose vaccine appointments are available during the Macomb County Health Department’s regularly scheduled COVID-19 vaccination clinic hours at the Verkuilen Building in Clinton Township and the Southwest Center in in Warren/Majestic Plaza; for details, visit https://www.macombgov.org/VaccineCentral. To make an appointment for a third dose, visit https://www.macombgov.org/healthappointment. Individuals who need help making an appointment can call the Macomb County Helpline at 586-463-3750. Although not encouraged, walk-up appointments are also welcome.

At this time, the FDA and CDC did not approve or recommend boosters for Individuals who initially received the Moderna or Johnson & Johnson (Janssen) COVID-19 vaccine.

View the original article.